CLDN

Celladon Corporation

A San Diego biotechnology company that developed gene therapies for heart disease, founded around 2000. Its lead experimental treatment, MYDICAR, delivered a working copy of a calcium-regulating gene into heart muscle cells to help failing hearts pump more effectively. The name MYDICAR plays on the heart muscle itself, blending "myo" (muscle) with the cardiac theme of the therapy.

No Schedule 13D or 13G filings recorded.